Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 2 drugs
Investigational
Matched Synonyms: … Hafnium oxide-containing nanoparticles nbtxr3 …
Matched Name: … Hafnium oxide …
Matched Iupac: … hafnium(4+) dioxidandiide …
Lutetium Lu-177 vipivotide tetraxetan is a radioligand therapeutic agent. It consists of a radionuclide, lutetium Lu-177, linked to a moiety that binds to PSMA, a transmembrane protein that is expressed in prostate cancer. Lutetium Lu-177 vipivotide tetraxetan was first approved by the FDA on March 23, 2022 as a treatment...
Approved
Displaying all 2 drugs